This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
5-APB: Difference between revisions
>Unity No edit summary |
>Unity No edit summary |
||
| Line 5: | Line 5: | ||
| ''[[ 5-APB/Summary|Summary sheet: 5-APB]]'' | | ''[[ 5-APB/Summary|Summary sheet: 5-APB]]'' | ||
|} | |} | ||
'''1-Benzofuran-5-ylpropan-2-amine''' (abbreviated '''5-APB''' ) is a [[Psychoactive class::entactogen]]ic substance of the [[chemical class::phenethylamine]] and [[chemical class::benzofuran]] classes. | '''1-Benzofuran-5-ylpropan-2-amine''' (abbreviated '''5-APB''') is a [[Psychoactive class::entactogen]]ic substance of the [[chemical class::phenethylamine]] and [[chemical class::benzofuran]] classes. | ||
This compound is known for its [[stimulating]] and [[euphoria|euphoric]] effects which has resulted in its rise in popularity as a product which is easily accessible through the use of certain online [[research chemical]] vendors. It has been sold as a [[designer drug]] since 2010.<ref>EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA | http://www.emcdda.europa.eu/publications/implementation-reports/2010</ref> | This compound is known for its [[stimulating]] and [[euphoria|euphoric]] effects which has resulted in its rise in popularity as a product which is easily accessible through the use of certain online [[research chemical]] vendors. It has been sold as a [[designer drug]] since 2010.<ref>EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA | http://www.emcdda.europa.eu/publications/implementation-reports/2010</ref> | ||